Identification of latent biomarkers in hepatocellular carcinoma by ultra-deep whole-transcriptome sequencing.
about
Genome-wide analysis of microRNA and mRNA expression signatures in cancerTCGA whole-transcriptome sequencing data reveals significantly dysregulated genes and signaling pathways in hepatocellular carcinoma.Hepatitis B virus genetic mutations and evolution in liver diseases.Prognostic and predictive biomarkers: tools in personalized oncology.RNA-seq identifies determinants of oxaliplatin sensitivity in colorectal cancer cell lines.Use of blood-based biomarkers for early diagnosis and surveillance of colorectal cancer.Transcriptome-Wide Analysis of Hepatitis B Virus-Mediated Changes to Normal Hepatocyte Gene Expression.Variations and mutations in the hepatitis B virus genome and their associations with clinical characteristicsIdentification of candidate anti-cancer molecular mechanisms of Compound Kushen Injection using functional genomics.Alternative RNA Splicing in the Pathogenesis of Liver Disease.Comparative analysis of oncogenes identified by microarray and RNA-sequencing as biomarkers for clinical prognosis.Identification and functional analysis of differentially expressed genes in poorly differentiated hepatocellular carcinoma using RNA-seq.Transcriptome profiling identifies a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma.Molecular Pathogenesis of Hepatocellular Carcinoma.Identification of important long non-coding RNAs and highly recurrent aberrant alternative splicing events in hepatocellular carcinoma through integrative analysis of multiple RNA-Seq datasets.A short isoform of ATG7 fails to lipidate LC3/GABARAP
P2860
Q26795603-8A5E2FCD-0C54-49E4-AFFA-0CD6B9308B3EQ30987443-5171316E-4C70-44AF-9062-6C82C4FD97D6Q33594925-D47CCD38-8928-44C9-8F74-CD4BD5599708Q33651583-A33D8976-C568-41CD-BEFB-8D4013E3AE6BQ34028959-25895719-974E-4270-876E-8C7F53AB7E87Q35148262-3C38C9E3-BED1-4674-8E87-E43D849B7040Q36593582-436ECCF5-6A32-4C05-82A4-1EB4EB2BD54CQ38408911-46F45CFA-C9DF-4E44-82A4-CDCB85E56D7AQ38747762-87C89990-FAD0-4483-933E-F0D3F779016CQ39416487-C708D5E4-A715-4F4C-92D1-7CDEECAC1326Q40393013-44D2B307-B209-41F9-A12F-189E2EF0C7E6Q41056051-BC2EEF29-AC14-4EEE-9D6B-39D5825E84A0Q41093037-DC4C763A-195D-4F06-BC5A-E9297E077196Q41544729-11C6B318-7235-4174-AC64-72E06706AFADQ53233480-7DF91395-DA8B-47F7-B794-3A36A3BBEAEDQ58695357-84678AC4-2FFB-47F7-9271-1212E61278CB
P2860
Identification of latent biomarkers in hepatocellular carcinoma by ultra-deep whole-transcriptome sequencing.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Identification of latent bioma ...... hole-transcriptome sequencing.
@en
Identification of latent bioma ...... hole-transcriptome sequencing.
@nl
type
label
Identification of latent bioma ...... hole-transcriptome sequencing.
@en
Identification of latent bioma ...... hole-transcriptome sequencing.
@nl
prefLabel
Identification of latent bioma ...... hole-transcriptome sequencing.
@en
Identification of latent bioma ...... hole-transcriptome sequencing.
@nl
P2093
P2860
P356
P1433
P1476
Identification of latent bioma ...... hole-transcriptome sequencing.
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2013.424
P407
P577
2013-10-21T00:00:00Z